Omnia SanaPlant Comparison
Greater Burdock vs Feverfew
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Greater Burdock and Feverfew: both belong to the Asteraceae family; they share 3 indicated uses (arthritis / joint pain, inflammation (general), skin irritation); 1 pharmacological action in common.
Evidence face-off — shared uses
| Condition | Greater Burdock | Feverfew | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 2/10 | 8/10 | Stronger for Feverfew |
| Inflammation (general) | 2/10 | 8/10 | Stronger for Feverfew |
| Skin irritation | 2/10 | 8/10 | Stronger for Feverfew |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
Burdock root is a rich source of prebiotic inulin-type fructans (fructooligosaccharides) along with chlorogenic and caffeic acids, the lignans arctiin and arctigenin, cynarine and quercetin, which underlie its antioxidant, anti-inflammatory and gut-supporting activity.
Parthenolide is the principal active compound, to which extracts are often standardised; it is biosynthesised and stored in the glandular trichomes of the aerial parts.
Supporting antioxidant and aromatic constituents.
Pharmacological Actions
Burdock (Arctium lappa) extracts and the lignan arctigenin inhibit proliferation and induce apoptosis in colon, breast, lung and gastric cancer cells, attenuate melanoma progression and reduce preneoplastic colon lesions in vivo (preclinical).
Traditional & Indicated Uses
inferred from anti-inflammatory action
inferred from digestive action
Arctium lappa root reduces diet-induced preneoplastic colon lesions and suppresses melanoma progression; its lignan arctigenin induces apoptosis in colon (HT-29), breast (in vitro/in vivo), lung and gastric cancer cells and chemosensitizes them to doxorubicin (preclinical).
inferred from digestive action
inferred from anti-inflammatory action
Traditional use for fever and for joint pain / arthritis
Traditional use for fever and for joint pain / arthritis
inferred from anti-inflammatory action
Migraine prophylaxis - reduces attack frequency (evidence favourable for some standardised preparations, though mixed); parthenolide is identified as the component responsible for the antimigraine effect in animal models
Traditional use for fever and for joint pain / arthritis
Safety, Cautions & Contraindications
Generally safe as a food plant. Allergic reactions are possible in those sensitive to Asteraceae. Avoid in pregnancy due to uterine-stimulating effects reported in animal studies. The burs (seed heads) can cause mechanical irritation of skin and eyes on contact. Not recommended in biliary obstruction.
Duke (2002) rates burdock as +++ and notes antibacterial, antimutagenic, antitumor, choleretic, diuretic, and prebiotic (bifidogenic) activities at the experimental level (score 1). The root is rich in inulin (a prebiotic fructooligosaccharide), which promotes growth of beneficial intestinal bacteria. Dose: 1–2 g dried root in tea three times daily, or 2–4 ml of tincture. Duke notes burdock's general safety, though it belongs to the Asteraceae family and can trigger reactions in sensitive individuals. It should be distinguished from belladonna and similar plants, which resemble it in early growth (Duke, 2002).
As a member of the daisy family (Asteraceae), it can cause allergic reactions in people sensitive to ragweed and related plants. Chewing fresh leaves commonly causes mouth ulcers and oral soreness.
Stopping feverfew abruptly after prolonged use can cause a 'post-feverfew' rebound of headache, anxiety and muscle/joint stiffness. Avoid in pregnancy (uterine-stimulant) and breastfeeding, and use caution with anticoagulant/antiplatelet medicines.
External Ids
Botanical Description
Robust biennial herb forming a large rosette of huge, heart-shaped (rhubarb-like), long-stalked leaves, dark green above and whitish-woolly beneath, in its first year. In the second year it sends up a tall, branching, grooved flowering stem bearing purple thistle-like flower heads enclosed in a globe of stiff, hooked bracts that ripen into the familiar clinging burrs.[1, 2]
Aromatic perennial herb (Asteraceae), 20-60 cm tall, with much-branched, downy stems. Leaves are yellow-green, bipinnately divided and strongly scented. Small, daisy-like flower heads have white ray florets and a flat yellow disc, borne in loose clusters.[13]
Habitat
A common weed of disturbed ground, waste places, roadsides, field margins and riverbanks on rich, moist soils; native to Europe and temperate Asia and naturalised in North America and elsewhere.[2]
Native to the Balkans and Caucasus region, now naturalised across Europe, North America and elsewhere; grows on disturbed ground, walls, roadsides and waste places, and is widely cultivated.[11]
Harvesting
The root is dug at the end of the first growing season (autumn) or early in the second spring, before the flowering stem develops, when it is at its most tender and richest in inulin; leaves are picked through the first year, and the seed/fruit is collected from the dried burrs in the second autumn. Careful identification against deadly nightshade, whose root can resemble burdock, is essential before digging.[11]
Leaves (aerial parts) are gathered during the growing season, ideally at flowering, and dried or used fresh.[13]
Traditional Uses
Feverfew has a long European folk tradition, its name derived from 'febrifuge' (fever-reducer), as a remedy for fevers, headaches and joint pain. Modern use and clinical research focus on migraine prevention, with parthenolide identified as the key active compound responsible for inhibiting the inflammatory pathways implicated in migraine.[11]
Preparations
Dried or fresh root simmered in water as a traditional alterative and digestive decoction.
Tincture of the dried root, ethanol 45% V/V or 25% V/V, 8-12 ml three times daily per the EU herbal monograph. The monograph states the ethanol strength but no drug-extract ratio, so no 1:5 ratio is claimed here. Educational reference only, not a prescription.
Fresh root peeled and cooked as a root vegetable (gobo), continuing the traditional food-medicine use.
Freeze-dried or standardised-parthenolide extract, the form used in most clinical trials.
Dosage
The EU herbal monograph on Arctium lappa L., radix gives, for adults and elderly, a single dose of 2-6 g of the comminuted root as an infusion, 3 times daily; a powdered herbal substance at 350 mg 3-5 times daily, a liquid extract at 2-8 mL 3 times daily and a soft extract at 0.2 g per dose (1-2 g daily) are also listed. Not recommended under 18 years, and a practitioner should be consulted if symptoms persist beyond 2 weeks. Educational reference only, not a prescription.
The EU herbal monograph gives 8-12 mL three times daily, for tinctures in either 45% V/V or 25% V/V ethanol, in adults and elderly. Educational reference only, not a prescription.
Clinical trials for migraine prevention have most often used standardised extracts providing around 0.2-0.6% parthenolide, taken daily; do not stop abruptly after prolonged use given a documented 'post-feverfew' rebound syndrome. Educational reference only, not a prescription; avoid in pregnancy and with anticoagulants.
References
Lookalikes Review
Dangerous Lookalikes
Not documented
Drug Class Interactions
Not documented
Pairings
Not documented
Feverfew and ginger both reduce blood clotting/platelet stickiness, so taking them together may add up and raise the risk of bruising or bleeding — use caution, especially before surgery or alongside blood-thinning drugs.[14, 15, 16]
References & Sources
- Chan, Y.S., Cheng, L.N., Wu, J.H., Chan, E., Kwan, Y.W., Lee, S.M.Y., Leung, G.P.H., Yu, P.H.F. and Chan, S.W (2010) 'A review of the pharmacological effects of Arctium lappa (burdock)', Inflammopharmacology, 19(5), pp. 245--254. doi:10.1007/s10787-010-0062-4 Preclinical
https://doi.org/10.1007/s10787-010-0062-4 - de Souza, A.R.C., de Oliveira, T.L., Fontana, P.D., Carneiro, M.C., Corazza, M.L., de Messias Reason, I.J. and Bavia, L (2022) 'Phytochemicals and Biological Activities of Burdock (Arctium lappa L.) Extracts: A Review', Chemistry and Biodiversity, 19(11). doi:10.1002/cbdv.202200615 Preclinical
https://doi.org/10.1002/cbdv.202200615 - Yosri, N., Alsharif, S.M., Xiao, J., Musharraf, S.G., Zhao, C., Saeed, A., Gao, R., Said, N.S., Di Minno, A., Daglia, M., Guo, Z., Khalifa, S.A.M. and El-Seedi, H.R (2023) 'Arctium lappa (burdock): insights from ethnopharmacology potential, chemical constituents, clinical studies, pharmacological utility and nanomedicine', Biomedicine & Pharmacotherapy, 158, pp. 114104. doi:10.1016/j.biopha.2022.114104 Meta-analysis / review
https://doi.org/10.1016/j.biopha.2022.114104 - Mondal, S.C. and Eun, J.B (2022) 'Mechanistic insights on burdock (Arctium lappa L.) extract effects on diabetes mellitus', Food Science and Biotechnology, 31(8), pp. 999--1008. doi:10.1007/s10068-022-01091-2 Preclinical
https://doi.org/10.1007/s10068-022-01091-2 - Shyam, M. and Sabina, E.P (2024) 'Harnessing the power of Arctium lappa root: a review of its pharmacological properties and therapeutic applications', Natural Products and Bioprospecting, 14(1), pp. 49. doi:10.1007/s13659-024-00466-8 Meta-analysis / review
https://doi.org/10.1007/s13659-024-00466-8 - Gao, Q., Yang, M. and Zuo, Z (2018) 'Overview of the anti-inflammatory effects, pharmacokinetic properties and clinical efficacies of arctigenin and arctiin from Arctium lappa L', Acta Pharmacologica Sinica, 39(5), pp. 787-801. doi:10.1038/aps.2018.32 Traditional / reference
https://doi.org/10.1038/aps.2018.32 - Jin, X., Liu, S., Chen, S., Wang, L., Cui, Y., He, J., Fang, S., Li, J. and Chang, Y (2023) 'A systematic review on botany, ethnopharmacology, quality control, phytochemistry, pharmacology and toxicity of Arctium lappa L. fruit', Journal of Ethnopharmacology, 308, pp. 116223. doi:10.1016/j.jep.2023.116223 Meta-analysis / review
https://doi.org/10.1016/j.jep.2023.116223 - Shukla, S., Kakade, M., Cherian, S., Alagarasu, K. and Parashar, D (2024) 'Arctigenin from Arctium lappa L. inhibits chikungunya virus by affecting its entry and replication', Phytomedicine, 128, pp. 155491. doi:10.1016/j.phymed.2024.155491 Preclinical
https://doi.org/10.1016/j.phymed.2024.155491 - Nascimento, B.A.C., Gardinassi, L.G., Silveira, I.M.G., Gallucci, M.G., Tome, M.A., Oliveira, J.F.D., Moreira, M.R.A., Meirelles, A.F.G., Faccioli, L.H., Tefe-Silva, C. and Zoccal, K.F (2019) 'Arctium lappa extract suppresses inflammation and inhibits melanoma progression', Medicines, 6(3), pp. 81. doi:10.3390/medicines6030081 Preclinical
https://doi.org/10.3390/medicines6030081 - Lu, N., Wei, J., Gong, X., Tang, X., Zhang, X., Xiang, W., Liu, S., Luo, C. and Wang, X (2023) 'Preventive effect of Arctium lappa polysaccharides on acute lung injury through anti-inflammatory and antioxidant activities', Nutrients, 15(23), pp. 4946. doi:10.3390/nu15234946 Preclinical
https://doi.org/10.3390/nu15234946 - Moro, T.M.A. and Clerici, M.T.P.S (2020) 'Burdock (Arctium lappa L) roots as a source of inulin-type fructans and other bioactive compounds: Current knowledge and future perspectives for food and non-food applications', Food Research International. doi:10.1016/j.foodres.2020.109889 Preclinical
https://doi.org/10.1016/j.foodres.2020.109889 - European Medicines Agency (HMPC) (2011) 'Community herbal monograph on Arctium lappa L., radix'. Available at: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-arctium-lappa-l-radix_en.pdf Traditional / reference
https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-arctium-lappa-l-radix_en.pdf - Royal Botanic Gardens, Kew (n.d.). Available at: https://powo.science.kew.org Traditional / reference
https://powo.science.kew.org - World Health Organization (2002) 'WHO Monographs on Selected Medicinal Plants'. Traditional / reference
https://scholar.google.com/scholar?q=WHO%20Monographs%20on%20Selected%20Medicinal%20Plants - Xu, Z., Li, Y., Jiang, D. and Deng, L (2008) 'Arctium lappa L.: A review of its traditional uses, phytochemistry, and pharmacology', 121(2), pp. 167--184. Traditional / reference
https://scholar.google.com/scholar?q=Arctium%20lappa%20L.%3A%20A%20review%20of%20its%20traditional%20uses%2C%20phytochemistry%2C%20and%20pharmacology - Romualdo, G.R., Silva, E.D.A., Da Silva, T.C., Aloia, T.P.A., Nogueira, M.S., De Castro, I.A. and others (2019) 'Burdock (Arctium lappa L.) root attenuates preneoplastic lesion development in a diet and thioacetamide-induced model of steatohepatitis-associated hepatocarcinogenesis', Environmental Toxicology, 35(4), pp. 518--527. doi:10.1002/tox.22887 Preclinical
https://doi.org/10.1002/tox.22887 - Chen, Y.-F. and Liu, R.-Z. and Ying, W.-W. and Yang, Y.-N. and Xiang, S.-F. and Shao, X.-J. and Cao, J. and Zhang, Y.-Q. and Yang, B. and He, Q.-J. and Ying, M.-D (2022) 'Arctigenin impairs UBC12 enzyme activity and cullin neddylation to attenuate cancer cells', Acta Pharmacologica Sinica, 44(3), pp. 661-669. doi:10.1038/s41401-022-00992-6 Preclinical
https://doi.org/10.1038/s41401-022-00992-6 - Shi, H. and Zhao, L. and Guo, X. and Fang, R. and Zhang, H. and Dong, G. and Fu, J. and Yan, F. and Zhang, J. and Ning, Z. and Ma, Q. and Li, Z. and Li, C. and Dai, J. and Si, C. and Xiong, H (2020) 'Arctigenin Attenuates Breast Cancer Progression through Decreasing GM-CSF/TSLP/STAT3/beta-Catenin Signaling', International Journal of Molecular Sciences, 21(17), pp. 6357. doi:10.3390/ijms21176357 Preclinical
https://doi.org/10.3390/ijms21176357 - Li, Q.-C. and Liang, Y. and Tian, Y. and Hu, G.-R (2016) 'Arctigenin induces apoptosis in colon cancer cells through ROS/p38MAPK pathway', Journal of BUON, 21(1), pp. 87-94. Preclinical
https://scholar.google.com/scholar?q=Arctigenin%20induces%20apoptosis%20in%20colon%20cancer%20cells%20through%20ROS/p38MAPK%20pathway - Lee, K.-S. and Lee, M.-G. and Kwon, Y.-S. and Nam, K.-S (2020) 'Arctigenin Enhances the Cytotoxic Effect of Doxorubicin in MDA-MB-231 Breast Cancer Cells', International Journal of Molecular Sciences, 21(8), pp. 2997. doi:10.3390/ijms21082997 Preclinical
https://doi.org/10.3390/ijms21082997 - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Bryson, P.D. and Watanabe, A.S. and Rumack, B.H. and Murphy, R.C (1978) 'Burdock root tea poisoning. Case report involving a commercial preparation', JAMA, 239(20), pp. 2157. Available at: https://pubmed.ncbi.nlm.nih.gov/642161/ Clinical study
https://pubmed.ncbi.nlm.nih.gov/642161/ - Berdai, M.A. and Labib, S. and Chetouani, K. and Harandou, M (2012) 'Atropa belladonna intoxication: a case report', Pan African Medical Journal, 11, pp. 72. Available at: https://pubmed.ncbi.nlm.nih.gov/22655106/ Clinical study
https://pubmed.ncbi.nlm.nih.gov/22655106/ - Oerlemans, C. and de Vries, I. and van Riel, A.J.H.P (2017) 'Anticholinergic syndrome caused by contaminated herbal tea; acting swiftly to identify the source', Nederlands Tijdschrift voor Geneeskunde, 161, pp. D1261. Available at: https://pubmed.ncbi.nlm.nih.gov/28612694/ Clinical study
https://pubmed.ncbi.nlm.nih.gov/28612694/
- Ernst, E. and Pittler, M.H (2000) 'The efficacy and safety of feverfew (Tanacetum parthenium L.): an update of a systematic review', Public Health Nutrition, 3(4A), pp. 509-514. doi:10.1017/s1368980000000598 Meta-analysis / review
https://doi.org/10.1017/s1368980000000598 - Pittler, M.H., Vogler, B.K. and Ernst, E (2000) 'Feverfew for preventing migraine', Cochrane Database of Systematic Reviews, (3), pp. CD002286. doi:10.1002/14651858.CD002286 Meta-analysis / review
https://doi.org/10.1002/14651858.CD002286 - Pareek, A., Suthar, M., Rathore, G.S. and Bansal, V (2011) 'Feverfew (Tanacetum parthenium L.): A systematic review', Pharmacognosy Reviews, 5(9), pp. 103-110. doi:10.4103/0973-7847.79105 Meta-analysis / review
https://doi.org/10.4103/0973-7847.79105 - Lopresti, A.L., Smith, S.J. and Drummond, P.D (2020) 'Herbal treatments for migraine: A systematic review of randomised-controlled studies', Phytotherapy Research, 34(10), pp. 2493-2517. doi:10.1002/ptr.6701 Meta-analysis / review
https://doi.org/10.1002/ptr.6701 - Pfaffenrath, V., Diener, H.C., Fischer, M., Friede, M. and Henneicke-von Zepelin, H.H (2002) 'The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis - a double-blind, multicentre, randomized placebo-controlled dose-response study', Cephalalgia, 22(7), pp. 523-532. doi:10.1046/j.1468-2982.2002.00396.x Randomized trial
https://doi.org/10.1046/j.1468-2982.2002.00396.x - Shrivastava, R., Pechadre, J.C. and John, G.W (2006) 'Tanacetum parthenium and Salix alba (Mig-RL) combination in migraine prophylaxis: a prospective, open-label study', Clinical Drug Investigation, 26(5), pp. 287-296. doi:10.2165/00044011-200626050-00006 Clinical study
https://doi.org/10.2165/00044011-200626050-00006 - Sur, R., Martin, K., Liebel, F., Lyte, P. and others (2009) 'Anti-inflammatory activity of parthenolide-depleted Feverfew (Tanacetum parthenium)', Inflammopharmacology, 17(1), pp. 42-49. doi:10.1007/s10787-008-8040-9 Preclinical
https://doi.org/10.1007/s10787-008-8040-9 - Darbahani, M., Rahaie, M., Ebrahimi, A. and Khosrowshahli, M (2022) 'The effects of several abiotic elicitors on the expression of genes of key enzymes involved in the parthenolide biosynthetic pathway and its content in feverfew plant (Tanacetum parthenium L.)', Natural Product Research, 36(23), pp. 6132-6136. doi:10.1080/14786419.2022.2055555 Preclinical
https://doi.org/10.1080/14786419.2022.2055555 - Jin, P., Madieh, S. and Augsburger, L.L (2008) 'Selected physical and chemical properties of Feverfew (Tanacetum parthenium) extracts important for formulated product quality and performance', AAPS PharmSciTech, 9(1), pp. 22-30. doi:10.1208/s12249-007-9017-5 Preclinical
https://doi.org/10.1208/s12249-007-9017-5 - Studzinska-Sroka, E., Znajdek-Awizen, P. and Gawron-Gzella, A (2013) 'Studies on the antimigraine action of Feverfew (Tanacetum parthenium (L.) Sch. Bip.)', Wiadomosci Lekarskie, 66(2 Pt 2), pp. 195-199. Meta-analysis / review
https://scholar.google.com/scholar?q=Studies%20on%20the%20antimigraine%20action%20of%20Feverfew%20%28Tanacetum%20parthenium%20%28L.%29%20Sch.%20Bip.%29 - Wider, B., Pittler, M.H. and Ernst, E (2015) 'Feverfew for preventing migraine', Cochrane Database of Systematic Reviews. doi:10.1002/14651858.CD002286.pub3 Meta-analysis / review
https://doi.org/10.1002/14651858.CD002286.pub3 - Tassorelli, C. and Greco, R. and Morazzoni, P. and Riva, A. and Sandrini, G. and Nappi, G (2005) 'Parthenolide is the component of Tanacetum parthenium that inhibits nitroglycerin-induced Fos activation: studies in an animal model of migraine', Cephalalgia, 25(8), pp. 612--621. doi:10.1111/j.1468-2982.2005.00915.x Randomized trial
https://doi.org/10.1111/j.1468-2982.2005.00915.x - Majdi, M. and Liu, Q. and Karimzadeh, G. and Malboobi, M.A. and Beekwilder, J. and Cankar, K. and de Vos, R. and Todorovic, S. and Simonovic, A. and Bouwmeester, H (2011) 'Biosynthesis and localization of parthenolide in glandular trichomes of feverfew (Tanacetum parthenium L. Schulz Bip.)', Phytochemistry, pp. 1739--1750. doi:10.1016/j.phytochem.2011.04.021 Preclinical
https://doi.org/10.1016/j.phytochem.2011.04.021 - Groenewegen, W.A. and Heptinstall, S (1990) 'A comparison of the effects of an extract of feverfew and parthenolide, a component of feverfew, on human platelet activity in-vitro', Journal of Pharmacy and Pharmacology, 42(8), pp. 553-557. doi:10.1111/j.2042-7158.1990.tb07057.x Preclinical
https://doi.org/10.1111/j.2042-7158.1990.tb07057.x - Ang-Lee, M.K., Moss, J. and Yuan, C.S (2001) 'Herbal medicines and perioperative care', JAMA, 286(2), pp. 208-216. doi:10.1001/jama.286.2.208 Meta-analysis / review
https://doi.org/10.1001/jama.286.2.208 - Jiang, X., Williams, K.M., Liauw, W.S., Ammit, A.J., Roufogalis, B.D., Duke, C.C., Day, R.O. and McLachlan, A.J (2005) 'Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects', British Journal of Clinical Pharmacology, 59(4), pp. 425-432. doi:10.1111/j.1365-2125.2005.02322.x Randomized trial
https://doi.org/10.1111/j.1365-2125.2005.02322.x
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.